Investment Thesis — MACOM Technology Solutions Holdings, Inc.
The market is extrapolating recent AI/defense chip momentum into perpetuity, but is underestimating how much of MACOM's growth is cyclical and tied to a handful of hyperscale and defense customers. Investors are paying up for a 'platform' narrative, but the company's pricing power and margin expansion are more fragile than consensus believes.
Catalysts
- Major customer order pushouts or cancellations
- Inventory correction in AI/defense supply chains
- Announcement of new, diversified design wins
Risk Factors
- Customer concentration risk with hyperscalers/defense
- Cyclical inventory corrections
- Execution missteps on new product ramps
Key Debates
Revenue growth accelerates past 25% by Q1'25, re-rating P/E.
50x P/E sustains as operating leverage drives EPS growth by Q4'24.
Analyst PT $242.63 validated by Q4'24 with 10% EPS beat.